Abstract
The iontophoresis of eight tripeptides, of the general structure alanine–X–alanine, has been measured across hairless mouse skin in vitro. The peptides were blocked (a) at the carboxyl terminus using the mixed anhydride reaction with t-butylamine and (b) at the amino terminus by acetylation with 14C-acetic anhydride. The nature of the central residue (X) was varied by selecting one of five neutral amino acids, two negatively chargeable moieties (aspartic and glutamic acids), and a positively chargeable species (histidine). Constant current iontophoresis at 0.36 mA/cm2, using Ag/AgCl electrodes, was performed for 24 hr in diffusion cells, which allowed both anode and cathode to be situated on the same (epidermal) side of a single piece of skin. Due to a combination of osmotic and electroosmotic forces, the anodal iontophoretic flux of neutral peptides was significantly greater than passive transport. Steady-state fluxes were not achieved, however, suggesting that time-dependent changes in the properties of the skin barrier may be occurring. Limited, further experiments confirmed that, on a 24-hr time scale, these changes were not fully reversible. The cathodal delivery of anionic permeants was well controlled at a steady and highly enhanced rate by the current flow. This behavior closely paralleled earlier work using simple negatively charged amino acids and N-acetylated amino acid derivatives. It appears that the normalized iontophoretic flux of these anionic species is independent of lipophilicity but may be inversely related to molecular weight. The positively charged peptide, Ac–Ala–His–Ala–NH(But), showed greater anodal iontophoretic enhancement when delivered from a donor solution at pH 4.0 than from a solution at pH 7.4. This was consistent with (a) the corresponding behavior of histidine alone and (b) the existence of a pK a for these compounds at ∼6. Steady-state delivery was not achieved, although the levels of enhancement, especially at pH 4, were the largest observed. A preliminary investigation of tripeptide stability to either (i) electrolysis in the donor compartment or (ii) cutaneous metabolism revealed very little degradation under the conditions of the experiment. Overall, this research supports the principle of enhanced peptide delivery across the skin by iontophoresis and indicates a number of areas (e.g., mechanism and extent of current-induced changes in skin barrier function, molecular size dependence, pathways of current flow) on which further work should be focused.
Similar content being viewed by others
REFERENCES
R. H. Guy and J. Hadgraft. Transdermal drug delivery: A perspective. J. Control. Rel. 4:237–251 (1987).
B. W. Barry. Dermatological Formulations—Percutaneous Absorption, Marcel Dekker, New York, 1983.
V. M. Knepp, R. H. Guy, and J. Hadgraft. Transdermal drug delivery: Promises and problems. CRC Crit. Rev. Ther. Drug Carrier Syst. 4:13–37 (1987).
K. A. Walters. Penetration enhancers. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery—Developmental Issues and Research Initiatives, Marcel Dekker, New York, 1989, pp. 197–246.
P. Tyle. Iontophoretic devices for drug delivery. Pharm. Res. 3:318–326 (1986).
R. R. Burnette. Iontophoresis. In J. Hadgraft and R. H. Guy (eds.), Transdermal Drug Delivery—Developmental Issues and Research Initiatives, Marcel Dekker, New York, 1989, pp. 247–291.
R. R. Burnette and D. Marrero. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across nude mouse skin. J. Pharm. Sci. 75:738–743 (1986).
Y. W. Chien, O. Siddiqui, W.-M. Shi, P. Lelawongs, and J.-C. Liu. Direct current iontophoretic transdermal delivery of peptide and protein drugs. J. Pharm. Sci. 78:376–383 (1989).
B. Kari. Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 35:217–221 (1986).
O. Siddiqui, Y. Sun, J.-C. Liu, and Y. W. Chien. Facilitated transdermal transport of insulin. J. Pharm. Sci. 76:341–345 (1987).
B. R. Meyer, H. L. Katzeff, J. C. Eschbach, J. Trimmer, S. B. Zacharias, S. Rosen, and D. Sibalis. Transdermal delivery of human insulin to albino rabbits using electrical current. Am. J. Med. Sci. 297:321–325 (1989).
P. G. Green, R. S. Hinz, C. Cullander, G. Yamane, and R. H. Guy. Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1113–1120 (1991).
A. Kim and F. C. Szoka. The distribution of tripeptides between octanol and water (submitted for publication).
P. Glikfeld, C. Cullander, R. S. Hinz, and R. H. Guy. A new system for in vitro studies of iontophoresis. Pharm. Res. 5:443–446 (1988).
R. C. Thomas. Ion-Selective Intracellular Microelectrodes: How to Make and Use Them, Academic Press, London, 1978.
R. R. Burnette and B. Ongpipattanakul. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76:765–773 (1987).
M. J. Pikal and S. Shah. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in the transport of low and high molecular weight solutes. Pharm. Res. 7:222–229 (1990).
Handbook of Chemistry and Physics, 69th ed., CRC Press, Boca Raton, FL, 1988.
J. R. Bond and B. W. Barry. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: Hydration damage. J. Invest. Dermatol. 90:486–489 (1988).
P. Glikfeld, R. S. Hinz, and R. H. Guy. Noninvasive sampling of biological fluids by iontophoresis. Pharm. Res. 6:988–990 (1989).
V. Srinivasan, W. I. Higuchi, and M.-H. Su. Baseline studies with the four-electrode system: The effects of skin permeability increase and water transport on the flux of a model uncharged solute during iontophoresis. J. Control. Rel. 10:157–165 (1989).
S. Del Terzo, C. R. Behl, and A. R. Nash. Iontophoretic transport of a homologous series of ionized and nonionized model compounds: Influence of hydrophobicity and mechanistic interpretation. Pharm. Res. 6:85–90 (1989).
J. C. Keister and G. B. Kasting. Ionic mass transport through a homogeneous membrane in the presence of a uniform electric field. J. Membrane Sci. 29:155–167 (1986).
J. B. Phipps, R. V. Padmanabhan, and G. A. Lattin. Iontophoretic delivery of model inorganic and drug ions. J. Pharm. Sci. 78:365–375 (1989).
L. Wearley, J.-C. Liu, and Y. W. Chien. Iontophoresis-facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability. J. Control. Rel. 9:231–242 (1989).
S. Grimnes. Pathways of ionic flow through human skin in vivo. Acta Derm. Venereol. 64:93–98 (1984).
R. R. Burnette and B. Ongpipattanakul. Characterization of the pore transport properties of excised human skin during iontophoresis. J. Pharm. Sci. 77:132–137 (1988).
M. J. Pikal. Transport mechanisms in iontophoresis. I. A theoretical model for the effect of electroosmotic flow on flux enhancement in transdermal iontophoresis. Pharm. Res. 7:118–126 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Green, P.G., Hinz, R.S., Kim, A. et al. lontophoretic Delivery of a Series of Tripeptides Across the Skin in Vitro . Pharm Res 8, 1121–1127 (1991). https://doi.org/10.1023/A:1015846100305
Issue Date:
DOI: https://doi.org/10.1023/A:1015846100305